Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1988-9-22
|
pubmed:abstractText |
Out of 32 patients (f = 10, m = 22; mean age: 46 +/- 3 years) with untreated essential (primary) hypertension (WHO-classification I-III) and without clinical signs of congestive heart failure or chronic renal failure, 19 showed plasma-ANP base levels above the normal range (greater than 100 pg/ml; normal range: 50 +/- 10 pg/ml). While high sodium loading caused an increase of plasma ANP levels and a concomitant decrease of plasma renin and aldosterone concentrations, low sodium loading caused the opposite pattern of ANP and renin/aldosterone secretion. Some patients with essential hypertension with highly elevated plasma ANP levels (10-20-fold above the normal range) showed an only moderate decrease of ANP and a slight increase of renin under a low sodium diet. Plasma ANP levels were significantly correlated with the heart volume (r = 0.54; p less than 0.05; radiologically determined), the electrocardiographic signs of left ventricular hypertrophy (Sokolow-Lyon index; r = 0.62; p less than 0.05) and with the left atrial diameter (r = 0.34; p less than 0.05; determined by 2-D-echocardiography). We speculate that high levels of plasma ANP in patients with essential hypertension might be interpreted as a compensatory mechanism either for an insufficient excretion of sodium or for myocardial dysfunction.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aldosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrocortisone,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0300-5860
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
77 Suppl 2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
92-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2970180-Adult,
pubmed-meshheading:2970180-Aldosterone,
pubmed-meshheading:2970180-Atrial Natriuretic Factor,
pubmed-meshheading:2970180-Blood Pressure,
pubmed-meshheading:2970180-Catecholamines,
pubmed-meshheading:2970180-Female,
pubmed-meshheading:2970180-Heart Diseases,
pubmed-meshheading:2970180-Humans,
pubmed-meshheading:2970180-Hydrocortisone,
pubmed-meshheading:2970180-Hypertension,
pubmed-meshheading:2970180-Male,
pubmed-meshheading:2970180-Middle Aged,
pubmed-meshheading:2970180-Reference Values,
pubmed-meshheading:2970180-Renin,
pubmed-meshheading:2970180-Sodium
|
pubmed:year |
1988
|
pubmed:articleTitle |
[Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?].
|
pubmed:affiliation |
Medizinische Klinik II, Universität Köln, Krankenanstalten Köln-Merheim.
|
pubmed:publicationType |
Journal Article,
English Abstract
|